Paden King, Ph.D.

Team Member of:
Dr. King is focused on the development of metal-based anticancer therapeutics. He will be applying his knowledge of inorganic chemistry in the lab to develop novel radiometal chelators and conjugates for cancer therapy.
1) metals chemistry, 2) radiochemistry, 3) cancer molecular radiotherapy
Contact Info
Center for Cancer Research
National Cancer Institute
Building 10, Room 1B55
Bethesda, MD 20892
Ph: 240-858-3062
paden.king@nih.gov
Selected Recent Publications
- Inorg Chem. 59(14): 10285-10303, 2020. [ Journal Article ]
- Chem Soc Rev. Epub ahead of print, 2020. [ Journal Article ]
- Angew Chem Int Ed Engl. Epub ahead of print, 2020. [ Journal Article ]
- Chem Sci. 11(10): 2627-2639, 2020. [ Journal Article ]
- ACS Med Chem Lett. 10(5): 822-827, 2019. [ Journal Article ]
Dr. Paden King was born and raised in the small town of Statenville, GA. Upon graduating high school, he proceeded to attend Mercer University, where he received Bachelor’s degrees in Chemistry and English Literature. His interest in medicinal chemistry led him to pursue his Ph.D. in bioinorganic chemistry at Cornell University where he worked in the laboratory of Professor Justin Wilson. While at Cornell, Dr. King focused on the development of metal-based anticancer therapeutics. Dr. King received his Ph.D. from Cornell in 2020 and has now joined Dr. Escorcia’s Lab so that he may apply his knowledge of inorganic chemistry to the development of novel radiometal chelators and conjugates for cancer therapy.